Insulin ' s high cost goes beyond drugmakers to industry ' s price mediators

Eli Lilly & Co.’s announcement that it is slashing prices for its major insulin products could make life easier for some diabetes patients while easing pressure on Big Pharma. It also casts light on the profiteering methods of the drug industry’s price mediators – the pharmacy benefit managers, or…#elilillycos #bigpharma #lilly #davidricks #seandickson #medicaid #sanofi #novonordisk #rebeccakelly #richmond
Source: Reuters: Health - Category: Consumer Health News Source Type: news